Lista de obras -

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

artículo científico publicado en 2023

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

artículo científico publicado en 2018

Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy

artículo científico publicado en 2023

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

scientific article published in 2022

Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity

artículo científico publicado en 2018

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

artículo científico publicado en 2019

Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy ⬇️

artículo científico publicado el 14 de enero de 2011

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

artículo científico publicado en 2022

Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161hi CD8α+ semi-invariant T cells ⬇️

artículo científico publicado el 25 de julio de 2011

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.

artículo científico publicado en 2017

Overlap and Effective Size of the Human CD8 + T Cell Receptor Repertoire ⬇️

artículo científico publicado el 1 de septiembre de 2010

Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

artículo científico publicado en 2021

Reply

scientific article published on 23 March 2019

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy